Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Immunology

• Publication date

  2008-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.4049/jimmunol.181.6.3933PMID 18768848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

  2008cited by this paper
• Mesenchymal cells recruit and regulate T regulatory cells.

  2008cited by this paper
• Functional and Phenotypic Alteration of Intrasplenic Lymphocytes Affected by Mesenchymal Stem Cells in a Murine Allosplenocyte Transfusion Model

  2007cited by this paper
• A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells.

  2007cited by this paper
• Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

  2007cited by this paper
• Immune regulation by mesenchymal stem cells: two sides to the coin.

  2007cited by this paper
• Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model

  2006cited by this paper
• Association of estrogen receptor-alpha genepolymorphisms with venous thrombosis.

  2006cited by this paper
• Specificity of CD4+CD25+ Regulatory T Cell Function in Alloimmunity1

  2006cited by this paper
• Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34 -Derived and Monocyte-Derived Dendritic Cells

  2006cited by this paper
• Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft.

  2006cited by this paper
• Cellular and molecular mechanisms of liver tolerance

  2006cited by this paper
• Human Mesenchymal Stem Cells Induce T Cell Anergy and Downregulate T Cell Allo-Responses via the TH2 Pathway: Relevance to Tissue Engineering Human Heart Valves

  2006cited by this paper
• Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.

  2006influential reference
• Mesenchymal stem cells in immunoregulation

  2006cited by this paper
• Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment.

  2006cited by this paper
• Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells1

  2006cited by this paper
• Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.

  2005cited by this paper
• Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.

  2005cited by this paper
• Pretransplant Donor Peripheral Blood Mononuclear Cells Infusion Induces Transplantation Tolerance by Generating Regulatory T Cells

  2005cited by this paper
• Natural versus adaptive regulatory T cells.

  2005cited by this paper
• Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway

  2005cited by this paper
• Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

  2005influential reference
• Mesenchymal stem cells avoid allogeneic rejection

  2005cited by this paper
• Organ transplantation—how much of the promise has been realized?

  2005cited by this paper
• Liver sinusoidal endothelial cells contribute to alloreactive T‐cell tolerance induced by portal venous injection of donor splenocytes

  2005cited by this paper
• Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

  2005cited by this paper
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

  2004cited by this paper
• Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow.

  2004cited by this paper
• Tregs and transplantation tolerance.

  2004cited by this paper
• Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.

  2004influential reference
• Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

  2004cited by this paper
• Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution

  2003cited by this paper
• HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

  2003cited by this paper
• Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens1

  2003cited by this paper
• Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

  2003cited by this paper
• Characterization and functionality of cell surface molecules on human mesenchymal stem cells.

  2003cited by this paper
• Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats

  2003cited by this paper
• Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.

  2003influential reference
• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  2003cited by this paper
• Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

  2003cited by this paper
• Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates.

  2003cited by this paper
• Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.

  2003cited by this paper
• The complementary roles of deletion and regulation in transplantation tolerance

  2003cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002influential reference
• Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

  2002influential reference
• CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1

  2002cited by this paper
• Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning

  2002cited by this paper
• Polycythemia vera: myths, mechanisms, and management.

  2002cited by this paper
• Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

  2002cited by this paper
• Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells.

  2002cited by this paper
• Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats1

  2002cited by this paper
• Challenges to achieving clinical transplantation tolerance.

  2001cited by this paper
• The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion

  2001cited by this paper
• Donor MHC Class II Antigen Is Essential for Induction of Transplantation Tolerance by Bone Marrow Cells1

  2000cited by this paper
• Role of mesenchymal stem cells in hematopoietic stem cell transplantation

  2000cited by this paper
• Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

  2000cited by this paper
• Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation

  1999cited by this paper
• Peripheral donor leukocytes prolong survival of rat renal allografts.

  1999cited by this paper
• A strategy for organ allografts without using immunosuppressants or irradiation.

  1998cited by this paper
• Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injection

  1994cited by this paper
• "Infectious" transplantation tolerance

  1993cited by this paper
• Intrathymic Injection of Donor Alloantigens Induces Donor‐specific Vascularized Allograft Tolerance Without Immunosuppression

  1992cited by this paper
• Specific manipulation in vivo of immunity to skin grafts bearing multiple minor histocompatibility differences.

  1991cited by this paper
• Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation.

  1990cited by this paper
• PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE: THE ROLE OF H‐2D, H‐2K, AND NON‐H-2 ANTIGENS IN REJECTION

  1973cited by this paper

• The Therapeutic Use and Potential of MSCs: Advances in Regenerative Medicine

  2025cites this paper
• Use of regulatory cells for achieving functional tolerance of pig heart xenotransplants in humans: a literature review

  2025cites this paper
• Alpha-1 Antitrypsin Overexpressing Mesenchymal Stem/Stromal Cells Reverses Type 1 Diabetes via Promoting Treg Function and CD8+ T cell exhaustion

  2025cites this paper
• The myeloid switch: immune drivers in atopic dermatitis — roles in pathogenesis and emerging therapeutic targeting

  2025cites this paper
• Mesenchymal stem cells for rheumatoid arthritis

  2025cites this paper
• Das therapeutische Potenzial von extrazellulären Vesikeln von mesenchymalen Stromazellen

  2024cites this paper
• Comparison of Autologous and Allogeneic Adipose-Derived Stem Cells in Kidney Transplantation: Immunological Considerations and Therapeutic Efficacy

  2024cites this paper
• Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions

  2024cites this paper
• Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell induction

  2024cites this paper
• Skin repair and immunoregulatory effects of myeloid suppressor cells from human cord blood in atopic dermatitis

  2024cites this paper
• Timing of Mesenchymal Stromal Cell Therapy Defines its Immunosuppressive Effects in a Rat Lung Transplantation Model

  2023influential citation
• Graft preservation in heart transplantation: current approaches

  2023cites this paper
• Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia

  2022cites this paper
• Pathophysiology and genetics of salt-sensitive hypertension

  2022cites this paper
• Commentary: Donor-specific tolerance in heart transplantation: A marathon, not a sprint.

  2022cites this paper
• BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1

  2022cites this paper
• THE TELL-TALE HEART. MACHINE PERFUSION IN HEART TRANSPLANTATION

  2022cites this paper
• Prediction and identification of epitopes in 1 the Echinococcus multilocularis 2 thrombospondin 3 antigen

  2022cites this paper
• Corneal Regeneration Using Adipose-Derived Mesenchymal Stem Cells

  2022cites this paper
• Prediction and identification of epitopes in the Echinococcus multilocularis thrombospondin 3 antigen

  2022cites this paper
• A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance

  2021cites this paper
• Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation

  2021cites this paper
• Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1/IRF3-regulated-IFN-γ production.

  2021cites this paper
• Advances and Perspectives in Dental Pulp Stem Cell Based Neuroregeneration Therapies

  2021cites this paper
• Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases

  2021cites this paper
• Placental Mesenchymal Stromal Cells: Preclinical Safety Evaluation for Fetal Myelomeningocele Repair.

  2021cites this paper
• Immunsuppressive Wirkung von Mitomycin-C-behandelten mononukleären Zellen des peripheren Blutes (MICs) in der Vaskularisierten Composite Allotransplantation

  2021cites this paper
• Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls

  2021cites this paper
• BMSCs improve TNBS-induced colitis in rats through inducing Tregs differentiation by expressing PD-L1

  2021cites this paper
• Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy

  2021cites this paper
• Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells

  2021cites this paper
• Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells

  2021cites this paper
• Immunomodulating Profile of Dental Mesenchymal Stromal Cells: A Comprehensive Overview

  2021cites this paper
• Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.

  2021cites this paper
• Graft infusion of adipose‐derived mesenchymal stromal cells to prevent rejection in experimental intestinal transplantation: A feasibility study

  2021cites this paper
• Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection

  2020cites this paper
• Detection and Monitoring of Regulatory Immune Cells Following Their Adoptive Transfer in Organ Transplantation

  2020cites this paper
• Third‐party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial

  2020cites this paper
• Strategies to achieve immune tolerance in allogeneic solid organ transplantation.

  2020cites this paper
• Dose- and Time-Dependent Effects of Human Mesenchymal Stromal Cell Infusion on Cardiac Allograft Rejection in Mice

  2020cites this paper
• Cellular therapies in organ transplantation

  2020cites this paper
• Mesenchymal Stem Cells for Regenerative Medicine for Duchenne Muscular Dystrophy

  2020cites this paper
• Cell therapy during machine perfusion

  2020cites this paper
• TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo

  2020cites this paper
• Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress

  2020cites this paper
• The Delivery of Multipotent Adult Progenitor Cells to Extended Criteria Human Donor Livers Using Normothermic Machine Perfusion

  2020cites this paper
• Co-transplantation of bone marrow mesenchymal stem cells and monocytes in the brain stem to repair the facial nerve axotomy

  2020cites this paper
• Fibroblasts as an Alternative to Mesenchymal Stem Cells with Successful Treatment and Immune Modulation in EAE Model of Multiple Sclerosis

  2020cites this paper
• Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation

  2020cites this paper
• Molecular mechanism for impaired suppressive function of Tregs in autoimmune diseases: A summary of cell‐intrinsic and cell‐extrinsic factors

  2020cites this paper
• Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model

  2020cites this paper
• Characterization of the immunomodulatory properties of alveolar bone-derived mesenchymal stem cells

  2020cites this paper
• Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery

  2020cites this paper
• Immunoregulatory properties of mesenchymal stem cells and their application in immunotherapy

  2020cites this paper
• Immunoregulation in the Hematopoietic Stem Cell Niche

  2020cites this paper
• Overexpression of alpha‐1 antitrypsin in mesenchymal stromal cells improves their intrinsic biological properties and therapeutic effects in nonobese diabetic mice

  2020cites this paper
• Engineering magnetic nanoparticles for repairing nerve injuries

  2020cites this paper
• Robustness Testing of Mesenchymal Stem Cell Monotherapy Following Vascularized Composite Allotransplantation

  2020cites this paper
• Extracellular Vesicles isolated from Mesenchymal Stromal Cells Modulate CD4+ T Lymphocytes Toward a Regulatory Profile

  2020cites this paper
• Autologous adipose mesenchymal stem cell administration in arteriosclerosis and potential for anti-aging application: a retrospective cohort study

  2020cites this paper
• Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).

  2020cites this paper
• Immunological organ modification during Ex Vivo machine perfusion: The future of organ acceptance.

  2020cites this paper
• Применение мультипотентных мезенхимальных стромальных клеток костного мозга при трансплантации почки

  2019cites this paper
• iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants

  2019cites this paper
• Применение мультипотентных мезенхимальных стромальных клеток костного мозга при трансплантации почки

  2019cites this paper
• Mesenchymal stem cell-derived extracellular vesicles improve the molecular phenotype of isolated rat lungs during ischemia/reperfusion injury.

  2019cites this paper
• Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.

  2019cites this paper
• Cyclosporine A promotes the therapeutic effect of mesenchymal stem cells on transplantation reaction.

  2019cites this paper
• HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy

  2019cites this paper
• Mesenchymal stromal cells in kidney transplantation

  2019cites this paper
• Immune Tolerance and Rejection in Organ Transplantation.

  2019cites this paper
• Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs

  2019cites this paper
• C-kit-derived CD11b+ cells are critical for cardiac allograft prolongation by autologous C-kit+ progenitor cells.

  2019cites this paper
• Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Pro-Tolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.

  2019cites this paper
• Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration

  2019cites this paper
• Mesenchymal Stromal Cells for Transplant Tolerance

  2019influential citation
• Update on mesenchymal stromal cell studies in organ transplant recipients.

  2019cites this paper
• A single administration of human adipose tissue‐derived mesenchymal stromal cells (MSC) induces durable and sustained long‐term regulation of inflammatory response in experimental colitis

  2019cites this paper
• Indoleamine 2,3-dioxgenase-transfected mesenchymal stem cells suppress heart allograft rejection by increasing the production and activity of dendritic cells and regulatory T cells

  2019cites this paper
• Contemporary Strategies and Barriers to Transplantation Tolerance

  2018cites this paper
• Inhibition of lymphocyte proliferation: An ability shared by murine mesenchymal stem cells, dermal fibroblasts and chondrocytes.

  2018cites this paper
• Induction of CD4+CD25+Foxp3+ regulatory T cells by mesenchymal stem cells is associated with RUNX complex factors

  2018cites this paper
• Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation

  2018cites this paper
• Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance

  2018cites this paper
• ABCB 5 Identifies Immunoregulatory Dermal Cells Graphical Abstract Highlights

  2018cites this paper
• Induction of CD4+CD25+FOXP3+ regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation

  2018cites this paper
• Exosomes Derived from IDO1-Overexpressing Rat Bone Marrow Mesenchymal Stem Cells Promote Immunotolerance of Cardiac Allografts

  2018cites this paper
• The effects of local administration of mesenchymal stem cells on rat corneal allograft rejection

  2018cites this paper
• Atenuación del rechazo inmunitario con células madre mesenquimales derivadas de tejido adiposo en un modelo experimental murino de trasplante de pulmón

  2018cites this paper
• Substance P blocks the impairment of paracrine potential of MSC due to long term culture

  2018cites this paper
• The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation

  2018cites this paper
• Mesenchymal Stromal Cell Therapy for Solid Organ Transplantation.

  2018cites this paper
• Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cells.

  2018cites this paper
• Immune modulation by apoptotic dental pulp stem cells in vivo.

  2018cites this paper
• Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome : The beginning of the

  2018cites this paper
• A gene-based approach to experimental heart transplant rejection

  2018cites this paper
• Mesenchymal Stem Cells Tolerance Induction with FK506 Immunosuppression in Rabbit Submandibular Gland Allotransplantation

  2018cites this paper
• Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway.

  2018cites this paper
• Protective action of bone marrow mesenchymal stem cells in immune tolerance of allogeneic heart transplantation by regulating CD45RB+ dendritic cells

  2018cites this paper
• Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning

  2018cites this paper